Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 09, 2025 16:15 ET | Source: Amarin Corporation plc

New REDUCE-IT® Aspirin Analysis Presented at AHA Scientific Sessions 2025 Reinforces VASCEPA®/VAZKEPA® (Icosapent Ethyl) Reduced Cardiovascular Events in High-Risk Patients

DUBLIN and BRIDGEWATER, N.J., Nov. 09, 2025 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN), a company committed to advancing the science of cardiovascular care, today highlighted a...
November 05, 2025 16:14 ET | Source: Seneca Foods Corp.

Seneca Foods Reports Sales and Earnings for the Quarter and Six Months Ended September 27, 2025

Seneca Foods Reports Sales and Earnings for the Quarter and Six Months Ended September 27, 2025
November 05, 2025 04:54 ET | Source: Research and Markets

U.S. Processed Pumpkin Market: Seasonal Demand & Growth Forecast (2025-2033) Featuring Libby's, Del Monte Foods, Great American Spice Company, Kerr by Ingredion, Seneca Foods and Other Leading Players

Dublin, Nov. 05, 2025 (GLOBE NEWSWIRE) -- The "United States Processed Pumpkin Market - Seasonal Demand & Forecast 2025-2033" has been added to ResearchAndMarkets.com's offering.The United...
November 03, 2025 08:30 ET | Source: Amarin Corporation plc

Amarin To Present New Analyses Affirming Robustness of Data from REDUCE-IT and Additional Mechanisms of Action of Eicosapentaenoic Acid (EPA) at American Heart Association (AHA) Scientific Sessions 2025

DUBLIN and BRIDGEWATER, N.J., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN), a company committed to advancing the science of cardiovascular care, today announced it will be...
October 30, 2025 09:00 ET | Source: Eagleview

Eagleview Sees New Market Trends; More Than 50 Unexpected and Emerging Use Cases For High-Resolution Aerial Imagery

Rochester, NY, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Eagleview, a leading provider of aerial imagery and asset intelligence, has observed an uptick in new market trends related to the potential uses of...
October 26, 2025 19:30 ET | Source: Biogen Inc.

Health Canada Grants Authorization for “LEQEMBI®” (lecanemab) for the Treatment of Early Alzheimer’s Disease

TOKYO and CAMBRIDGE, Mass., Oct. 26, 2025 (GLOBE NEWSWIRE) -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge,...
October 22, 2025 16:02 ET | Source: Ventyx Biosciences, Inc.

Ventyx Biosciences Announces Positive Topline Results from Phase 2 Study of VTX3232 in Participants with Obesity and Cardiovascular Risk Factors

VTX3232 demonstrated significant reductions in cardiovascular risk factors, with additional benefits when combined with semaglutide VTX3232 monotherapy achieved ~80% reduction in hsCRP within the...
October 14, 2025 09:00 ET | Source: Eagleview

Eagleview Unveils Eagleview Labs to Drive Geospatial Innovation and Unlock New Market Applications

Rochester, NY, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Eagleview, a leading provider of aerial imagery and asset intelligence, has launched Eagleview Labs, a dedicated innovation center designed to expand...
October 14, 2025 08:00 ET | Source: Amarin Corporation plc

Amarin and HLS Therapeutics Collaborate on Presenting REDUCE-IT® and EPA Mechanistic Data at the Canadian Cardiovascular Congress

DUBLIN, Ireland and BRIDGEWATER, N.J., Oct. 14, 2025 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN), a company committed to advancing the science of cardiovascular care, in collaboration...
October 13, 2025 19:30 ET | Source: Biogen Inc.

LEQEMBI® IQLIK™(lecanemab-irmb) Subcutaneous Autoinjector Named to TIME’s “Best Inventions of 2025”

TOKYO and CAMBRIDGE, Mass., Oct. 13, 2025 (GLOBE NEWSWIRE) -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Headquarters: Cambridge, Massachusetts,...